10-Q Filing

YUBO INTERNATIONAL BIOTECH LTD CIK: 895464 Q3 2021

Filing Information

Form Type	10-Q
Accession Number	`0001640334-21-000131`
Period End Date	20201130
Filing Date	20210119
Fiscal Year	2021
Fiscal Period	Q3
XBRL Instance	yubo-20201130.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 38 Income Statement 52 Cash Flow Statement 45 Stockholders Equity 31

Balance Sheet 38 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash	`Cash`	$1.00K	USD	Point-in-time
Cash	`Cash`	-	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	5.00M	shares	Point-in-time
Total current assets	`AssetsCurrent`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.00K	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayable`	$1.41M	USD	Point-in-time
Notes payable and accrued interest payable to related parties	`NotesPayable`	-	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Due to related parties	`DueToRelatedPartiesCurrent`	-	USD	Point-in-time
Accounts payable	`AccountsPayableOtherCurrent`	$9.69K	USD	Point-in-time
Accounts payable	`AccountsPayableOtherCurrent`	$353.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$40.00K	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	-	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.80M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$9.69K	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS AND CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock value	`PreferredStockValue`	-	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$28.71M	USD	Point-in-time
Additional paid in capital	`AdditionalPaidInCapital`	$27.29M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-28.84M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-29.09M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.77M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.73M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.83M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.48M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Total stockholders' deficit	`StockholdersEquity`	$-9.69K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	$1.00K	USD	Point-in-time
Total liabilities and stockholders' deficit	`LiabilitiesAndStockholdersEquity`	-	USD	Point-in-time

Income Statement 52 line items

Line Item	Tag	Value	Unit	Period
REVENUES	`Revenues`	-	USD	3 Qtrs
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	1 Quarter
REVENUES	`Revenues`	-	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$8.00K	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$53.48K	USD	3 Qtrs
General and administrative	`SellingGeneralAndAdministrativeExpense`	$25.48K	USD	1 Quarter
General and administrative	`SellingGeneralAndAdministrativeExpense`	$25.00K	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-25.48K	USD	1 Quarter
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-53.48K	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-25.00K	USD	3 Qtrs
LOSS FROM OPERATIONS	`OperatingIncomeLoss`	$-8.00K	USD	1 Quarter
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	3 Qtrs
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	$-191.00K	USD	3 Qtrs
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	1 Quarter
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	1 Quarter
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	$-167.00K	USD	3 Qtrs
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	-	USD	1 Quarter
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	-	USD	3 Qtrs
Gain from settlement of accounts payable and due to related party	`GainFromSettlementOfAccountsPayableAndDueToRelatedParty`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$78.00K	USD	3 Qtrs
Interest expense	`InterestExpense`	$26.00K	USD	1 Quarter
Interest expense	`InterestExpense`	-	USD	1 Quarter
Interest expense	`InterestExpense`	$53.00K	USD	3 Qtrs
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	$-78.00K	USD	3 Qtrs
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	$-26.00K	USD	1 Quarter
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income (expense) - net	`OtherNonoperatingIncomeExpense`	$305.00K	USD	3 Qtrs
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-103.00K	USD	3 Qtrs
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$251.51K	USD	3 Qtrs
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-34.00K	USD	1 Quarter
NET INCOME (LOSS) BEFORE INCOME TAX	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-25.48K	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxExpenseBenefit`	-	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-35.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-25.48K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-103.00K	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$251.51K	USD	3 Qtrs
NET INCOME (LOSS)	`NetIncomeLoss`	$311.00K	USD	1 Quarter
NET INCOME (LOSS)	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.18M	shares	3 Qtrs
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	1.18M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	89.67M	shares	1 Quarter
WEIGHTED AVERAGE NUMBER OF COMMON SHARES OUTSTANDING, BASIC AND DILUTED	`WeightedAverageNumberOfDilutedSharesOutstanding`	30.46M	shares	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.03	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	-	USD	1 Quarter
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.09	USD	3 Qtrs
Basic and diluted	`EarningsPerShareBasicAndDiluted`	$0.01	USD	3 Qtrs

Cash Flow Statement 45 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-35.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-25.48K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-103.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$251.51K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$311.00K	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
(Cayman Islands) and affiliates	`CaymanIslandsAndAffiliates`	-	USD	3 Qtrs
(Cayman Islands) and affiliates	`CaymanIslandsAndAffiliates`	$15.80K	USD	3 Qtrs
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	3 Qtrs
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	$-191.00K	USD	3 Qtrs
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	1 Quarter
Gain from debt extinguishment	`ExtinguishmentOfDebtAmount`	-	USD	1 Quarter
Gain from settlement of accounts payable	`GainLossRelatedToLitigationSettlement`	$-167.00K	USD	3 Qtrs
Gain from settlement of accounts payable	`GainLossRelatedToLitigationSettlement`	-	USD	3 Qtrs
Due to related parties	`IncreaseDecreaseInDueToRelatedParties`	$9.00K	USD	3 Qtrs
Accrued interest payable to related parties	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$53.00K	USD	3 Qtrs
Accrued interest payable to related parties	`IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities`	$83.00K	USD	3 Qtrs
Accounts payable and accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	-	USD	3 Qtrs
Accounts payable and accrued expenses and other current liabilities	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$17.69K	USD	3 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-20.00K	USD	3 Qtrs
NET CASH USED IN OPERATING ACTIVITIES	`NetCashProvidedByUsedInOperatingActivities`	$-11.00K	USD	3 Qtrs
Proceeds received from notes payable to related parties-	`ProceedsFromRelatedPartyDebt`	$17.00K	USD	3 Qtrs
Proceeds received from notes payable to related parties-	`ProceedsFromRelatedPartyDebt`	$10.00K	USD	3 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITES	`NetCashProvidedByUsedInFinancingActivities`	$10.00K	USD	3 Qtrs
NET CASH PROVIDED BY FINANCING ACTIVITES	`NetCashProvidedByUsedInFinancingActivities`	$17.00K	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-3.00K	USD	3 Qtrs
NET (DECREASE) INCREASE IN CASH	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-1.00K	USD	3 Qtrs
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
Beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	-	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$4.00K	USD	Point-in-time
End of period	`CashAndCashEquivalentsAtCarryingValue`	$1.00K	USD	Point-in-time
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for interest	`InterestPaidNet`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Cash paid for income taxes	`IncomeTaxesPaidNet`	-	USD	3 Qtrs
Conversion of notes payable and accrued interest into Class A common shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	-	shares	3 Qtrs
Conversion of notes payable and accrued interest into Class A common shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	1.47M	shares	3 Qtrs
Payment of accounts payable and accrued expenses by Activist Investing LLCpursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccountsPayableAndAccruedExpensesByActivistInvestingLlcpursuantToStockPurchaseAgreementDatedJune302020`	-	USD	3 Qtrs
Payment of accounts payable and accrued expenses by Activist Investing LLCpursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccountsPayableAndAccruedExpensesByActivistInvestingLlcpursuantToStockPurchaseAgreementDatedJune302020`	$49.00K	USD	3 Qtrs

Stockholders Equity 31 line items

Line Item	Tag	Value	Unit	Period
Balance, amount	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.77M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.73M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.83M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.48M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-9.69K	USD	Point-in-time
NET LOSS	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-35.00K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-25.48K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-103.00K	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$251.51K	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$311.00K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-34.00K	USD	1 Quarter
Payment of accounts payable and accrued expenses by Activist Investing LLC on July 2, 2020 pursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccountsPayableAndAccruedExpensesByActivistInvestingLlcOnJuly22020PursuantToStockPurchaseAgreementDatedJune302020`	$37.00K	USD	1 Quarter
Conversion of notes payable and Accrued interest to Class A shares on September 23, 2020, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	-	shares	3 Qtrs
Conversion of notes payable and Accrued interest to Class A shares on September 23, 2020, shares	`StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities`	1.47M	shares	3 Qtrs
Conversion of notes payable and Accrued interest to Class A shares on September 23, 2020, amount	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	$1.47M	USD	1 Quarter
Payment of accrued expenses ($3,000) and due to related parties ($9,000) by Activist Investing LLC in the three months ended November 30, 2020 pursuant to Stock Purchase Agreement dated June 30, 2020	`PaymentOfAccruedExpenses3000AndDueToRelatedParties9000ByActivistInvestingLlcInTheThreeMonthsEndedNovember302020PursuantToStockPurchaseAgreementDatedJune302020`	$12.00K	USD	1 Quarter
Company expenses paid by Platinum International Biotech Co. Ltd. (Cayman Islands) and affiliates	`CompanyExpensesPaidByPlatinumInternationalBiotechCoLtdCaymanIslandsAndAffiliates`	$15.80K	USD	1 Quarter
Adjustments, amount	`LitigationSettlementAmountAwardedToOtherParty`	-	USD	1 Quarter
Balance, amount	`StockholdersEquity`	$-1.80M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.77M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.73M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.66M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.83M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.48M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-1.70M	USD	Point-in-time
Balance, amount	`StockholdersEquity`	$-9.69K	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.